Brief: Rani Therapeutics Holdings Inc Class A Shares Open 2.4% Above IPO Price In Nasdaq Debut
July 30 (Reuters) -
* RANI THERAPEUTICS HOLDINGS INC CLASS A SHARES OPEN AT
$11.26 IN
NASDAQ DEBUT VERSUS IPO PRICE OF $11.00/SHARE
Further company coverage: RANI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rani Therapeutics Holdings
See all newsRani Therapeutics Q2 net loss narrows as revenue rises helped by Chugai agreement
Brief: Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Brief: Pegbio Co Enters MoU With Rani Therapeutics
Brief: Rani Therapeutics Announces R&D Collaboration With PegBio
Rani Therapeutics Q1 contract revenue rises on Chugai collaboration; announces CFO transition